Etonogestrel, Ethinyl Estradiol Vaginal Ring Articles
Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders
9 February 2009
S-P profit falls 21%, still up on predictions
27 October 2008
S-P profit down again on Organon charges
28 July 2008
S-P's 4th-qtr 2007 results hit by Organon buy
18 February 2008
Akzo Nobel's 2006 net income increases 20%
26 February 2007
Akzo's income hits 313M euro for 3rd-qtr
23 October 2006
Akzo Nobel's 2nd-qtr sales hit 3.57B euros
31 July 2006
Organon's NuvaRing approved in Australia
17 July 2006
High patient satisfaction for Organon's NuvaRing
15 May 2006
Akzo 2005 income rises 1.7%, Organon gains
13 February 2006
1st-qtr net doubles for Akzo Nobel
25 April 2005
Akzo Nobel's 4th-qtr and 2004 sales down
14 February 2005
Akzo Nobel does not rule out pharma sale
22 November 2004
Akzo's 2nd-qtr pharma sales slip further
26 July 2004
Akzo Nobel's pharma sales drop further
9 February 2004
Akzo Nobel pharma under pressure
27 October 2003
Akzo Nobel 1st qtr earnings plunge 30%
28 April 2003
Akzo Nobel cuts production in USA
21 April 2003
Akzo Nobel pharma unit
17 February 2003
NuvaRing available in US pharmacies
22 July 2002
Organon's free NuvaRing offer
13 May 2002
Akzo set to break record level profits
29 April 2002
Akzo Nobel to rely on organic growth in niche markets
28 February 2000
Showing 1-28 of 28 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
